Why is Lotus Eye Hospit falling/rising?

As of 12-Sep, Lotus Eye Hospital & Institute Ltd is experiencing a slight increase in its stock price, currently at 122.50, with a change of 0.5, representing a 0.41% rise. The stock has shown a trend reversal, gaining after two consecutive days of decline. Despite a recent drop in delivery volume by 45.79% against the 5-day average, the stock remains liquid enough for trading. Over the past year, it has generated a remarkable return of 61.72%, significantly outperforming the BSE500 index over various time frames, including a 65.88% increase over the last month and a 77.97% rise year-to-date. The company's low debt-to-equity ratio and the fact that the majority of shareholders are non-institutional also contribute positively to its stability and attractiveness.
In the broader market context, the stock's short-term performance of +0.62% over the past week is notably lower than the benchmark Sensex, which has risen by 1.48% during the same period. However, the long-term performance of Lotus Eye Hospital & Institute Ltd has been strong, with a 315.25% increase over the past five years compared to the Sensex's 110.80%. This indicates that while the stock may be facing some short-term challenges, its overall trajectory remains positive, supported by solid fundamentals and a history of market-beating returns.